Head of Hematology at Memorial Sloan Kettering Cancer Center

 

 

Dr. Gerald Soff, Chief of Hematology Service, Memorial Sloan Kettering Cancer Center (MSKCC), is a longtime supporter of ICRF. He deals with patients suffering with blood diseases, many with varying types of blood cancer, every working day.

A number of years ago and after several weeks of personal fatigue, Dr. Soff ordered a panel of routine blood tests on himself. The result was his diagnosis of multiple myeloma, a deadly form of bone marrow cancer.

When Dr. Soff was in medical training 30 years ago and until recently, patients diagnosed with multiple myeloma faced a life expectancy of two years...a pretty grim diagnosis. Thanks to a scientific breakthrough from two ICRF-funded scientists (see History of Multiple Myeloma below) for which they were awarded the Nobel Prize in Chemistry (2003), Dr. Soff was successfully treated with proteasome inhibitors, an effective cure for multiple myeloma.